Zinzino Sales Growth November 2025

December 10, 2025
Press Release

Zinzino AB (PUBL.): Preliminary Sales Report November 2025

Zinzino group revenue increased with a total of 45 %, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma’s external sales decreased and amounted to SEK 4.3 (10.1) million.

Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.

Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.

Revenues were distributed as follows:

Regions, MSEK	25-Nov	24-Nov	Change	YTD 2025	YTD 2024	Change
The Nordics	29.7	29.0	2%	301.0	272.3	11%
Central Europe	133.9	70.4	90%	892.2	518.7	72%
East Europe	51.5	51.6	0%	361.9	366.0	-1%
South & West Europe	58.7	45.3	30%	513.9	346.7	48%
The Baltics	17.3	16.1	7%	115.4	95.6	21%
North America	58.1	25.8	125%	491.0	179.2	174%
Asia-Pacific	23.0	11.1	107%	263.7	64.4	309%
Africa	2.8	2.5	12%	21.1	15.1	40%
Zinzino	375.0	251.8	49%	2960.2	1858.0	59%
Faun Pharma	4.3	10.1	-57%	47.3	97.1	-51%
Zinzino Group	379.3	261.9	45%	3007.5	1955.1	54%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

View as PDF

SOURCE: Zinzino

About Zinzino

Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.

Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita, Xelliss, and Sanki Global. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters are in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com

Get more information, facts and figures about Zinzino, click here for the Zinzino overview.

Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible at time of publishing. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.

Débora Morais